Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 58 9-Day RSI is 51.11 as of Jul. 30, 2026. GuruFocus rates TSE:6029 with a GF Score™ of 58/100 and a GF Value™ of 円140.07 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 696 Healthcare Providers & Services companies, Artra Group ranks worse than 56.9% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-30), Artra Group's 9-Day RSI is 51.11.
The industry rank for Artra Group's 9-Day RSI or its related term are showing as below:
TSE:6029's 9-Day RSI is ranked worse than 56.9% of 696
companies
in the Healthcare Providers & Services industry
Industry Median: 48.42
vs TSE:6029: 51.11
Artra Group (TSE:6029) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Artra Group 9-Day RSI Related Terms
TSE:6029 vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Artra Group's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Artra Group's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artra Group (TSE:6029) has a 9-Day RSI of 51.11 as of Jul. 30, 2026. According to the industry distribution chart, Artra Group ranks #396 out of 696 companies in the Healthcare Providers & Services industry, placing it in the top 56.9%.
Is Artra Group's 9-Day RSI too high?
Artra Group's current 9-Day RSI is 51.11. The Healthcare Providers & Services industry median 9-Day RSI is 48.42. Artra Group's value of 51.11 is 5.6% above this industry median. Based on the distribution chart, Artra Group ranks #396 out of 696 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Artra Group has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #396 out of 696 companies for 9-Day RSI. This places Artra Group in the lower half of its industry. The industry median 9-Day RSI is 48.42. Artra Group's value of 51.11 is 5.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 48.42, based on 696 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Artra Group's current 9-Day RSI of 51.11 is 5.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 48.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current 9-Day RSI is 51.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円140.07, compared to a current price of 円197.00 — trading 40.6% above its estimated fair value. The current 9-Day RSI is 51.11 and 5.6% above the Healthcare Providers & Services industry median of 48.42. Artra Group's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Artra Group (TSE:6029), the current 9-Day RSI is 51.11 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円197.00 is trading 40.6% above its estimated GF Value™ of 円140.07.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
9-Day RSI: 51.11
GF Value™: 円140.07 vs. price of 円197.00 (40.6% above fair value)
Industry Position: 5.6% above the Healthcare Providers & Services median (#396 of 696)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
58GF Score
Get the complete analysis for TSE:6029
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
